Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-17-026307

VP and Chief Compliance Office acquired 6,000 shares (grant or award)

  • VP and Chief Compliance Office gave up 1,796 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Herman James L VP and Chief Compliance Office 2017-04-07 Grant or award +6,000 $6.45 $38,700 44,744 D
Herman James L VP and Chief Compliance Office 2017-04-07 Shares withheld for taxes −1,796 $6.45 $11,584 42,948 D
Loading xslF345X03/doc4.xml…